Scripps Health


 

Updates in CLL: Treatment for BTKi-Refractory and BTKi/BCL-2i-Refractory Disease

189 views
March 18, 2024

Chapters

Venetoclax Data & MURANO Trial 7-Year Follow-Up

00:00

Pirtobrutinib Efficacy in BTKi-Refractory CLL Patients

05:34

Liso-cel CAR-T Data & Potential FDA Approval in CLL

12:02

Epcoritamab in CLL: Response Rates & MRD Undetectability

15:22

0 Comments
Login to view comments. Click here to Login